Menu
Back to User profile » Prof. Dr. Willem Verhoeven
Papers published by Prof. Dr. Willem Verhoeven:
Myoclonic-Atonic Epilepsy Caused by a Novel de Novo Heterozygous Missense Variant in the SLC6A1 Gene: Brief Discussion of the Literature and Detailed Case Description of a Severely Intellectually Disabled Adult Male Patient
Verhoeven W, Zuijdam J, Scheick A, van Nieuwenhuijsen F, Zwemer AS, Pfundt R, Egger J
International Medical Case Reports Journal 2022, 15:753-759
Published Date: 23 December 2022
A Patient with Moderate Intellectual Disability and 49, XXXYY Karyotype
Verhoeven WMA, Egger JIM, Mergler S, Meijer TAA, Pfundt R, Willemsen MH
International Journal of General Medicine 2022, 15:2799-2806
Published Date: 10 March 2022
A de novo CTNNB1 Novel Splice Variant in an Adult Female with Severe Intellectual Disability
Verhoeven WMA, Egger JIM, Jongbloed RE, Meijer van Putten M, de Bruin-van Zandwijk M, Zwemer AS, Pfundt R, Willemsen MH
International Medical Case Reports Journal 2020, 13:487-492
Published Date: 7 October 2020
Phenotypic characterization of an older adult male with late-onset epilepsy and a novel mutation in ASXL3 shows overlap with the associated Bainbridge-Ropers syndrome
Verhoeven W, Egger J, Räkers E, van Erkelens A, Pfundt R, Willemsen MH
Neuropsychiatric Disease and Treatment 2018, 14:867-870
Published Date: 27 March 2018
Cycloid psychoses in the psychosis spectrum: evidence for biochemical differences with schizophrenia
van de Kerkhof NW, Fekkes D, van der Heijden FM, Hoogendijk WJ, Stöber G, Egger JI, Verhoeven WM
Neuropsychiatric Disease and Treatment 2016, 12:1927-1933
Published Date: 2 August 2016
Absence epilepsy and the CHD2 gene: an adolescent male with moderate intellectual disability, short-lasting psychoses, and an interstitial deletion in 15q26.1–q26.2
Verhoeven WMA, Egger JIM, Knegt AC, Zuydam J, Kleefstra T
Neuropsychiatric Disease and Treatment 2016, 12:1135-1139
Published Date: 10 May 2016
Glycosylated hemoglobin as a screening test for hyperglycemia in antipsychotic-treated patients: a follow-up study
Steylen PMJ, van der Heijden FMMA, Hoogendijk WJG, Verhoeven WMA
Diabetes, Metabolic Syndrome and Obesity 2015, 8:57-63
Published Date: 23 January 2015
Neuropsychological phenotype of a patient with a de novo 970 kb interstitial deletion in the distal 16p11.2 region
Egger JI, Verhoeven WM, Verbeeck W, de Leeuw N
Neuropsychiatric Disease and Treatment 2014, 10:513-517
Published Date: 25 March 2014
Copy number variants in a sample of patients with psychotic disorders: is standard screening relevant for actual clinical practice?
Van de Kerkhof NW, Feenstra I, van der Heijden FM, De Leeuw N, Pfundt R, Stöber G, Egger JI, Verhoeven WM
Neuropsychiatric Disease and Treatment 2012, 8:295-300
Published Date: 12 July 2012
Phelan-McDermid syndrome in two adult brothers: atypical bipolar disorder as its psychopathological phenotype?
Verhoeven WMA, Egger JIM, Willemsen MH, de Leijer GJM, Kleefstra T
Neuropsychiatric Disease and Treatment 2012, 8:175-179
Published Date: 19 April 2012
Recurrent major depression, ataxia, and cardiomyopathy: association with a novel POLG mutation?
Verhoeven WMA, Egger JIM, Kremer BPH, de Pont BJHB, Marcelis CLM
Neuropsychiatric Disease and Treatment 2011, 7:293-296
Published Date: 15 May 2011
Recurrent schizophrenia-like psychosis as first manifestation of epilepsy: a diagnostic challenge in neuropsychiatry
Willem MA Verhoeven, Jos IM Egger, W Boudewijn Gunning, et al
Neuropsychiatric Disease and Treatment 2010, 6:227-231
Published Date: 3 May 2010
Top-down or bottom-up: Contrasting perspectives on psychiatric diagnoses
Willem MA Verhoeven, Siegfried Tuinier, Ineke van der Burgt
Biologics: Targets and Therapy 2008, 2:409-417
Published Date: 12 September 2008